Source: Annual Congress 2003 - Exhaled breath techniques and other aspects of lung inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. V. Kalenik, V. A. Nevzorova, E. N. Konovalova, S. A. Pazych, I. M. Martynuk (Vladivostok, Russia). Endothelial function of asthma patients in stable state and during exacerbation. Eur Respir J 2003; 22: Suppl. 45, 1810

Member's Comments

No comment yet.

Related content which might interest you: State of endothelial function in patients with COPD in stable state and during exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 Relationships between stable state inflammation and time to exacerbation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013 Differences in vessel endothelium function in severe COPD and severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Determinants of exacerbation rate in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Cilomilast decreases exacerbations and maintains lung function in patients with poorly reversible COPD Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004 Severe exacerbations predict excess lung function decline in asthma Source: Eur Respir J 2007; 30: 452-456 Year: 2007 Endothelial dysfunction and arterial rigidity in patients with bronchial asthma out of an exacerbation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Hypoxaemia and endothelial dysfunctional in patients with COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Evaluation of endothelial dysfunction at the patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 480s Year: 2002 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014